MedTrace Logo

Benefits of Opioid Free Anesthesia on Morphine Consumption in Gastric Bypass

NCT05004519 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 183

Last updated 2023-11-30

No results posted yet for this study

Summary

Opioid free anesthesia is a recent anesthesia technique with the aim to avoid peroperative use of morphinics to allow a diminution of secondary morphinics effects in the postoperative period.

There is no robust data on the real benefits of such procedures. Obese patients are particular at risk of secondary effects of opioids. The aim of our study is to compare opioid free anesthesia to multimodal anesthesia on postoperative morphine consumption after a laparoscopic gastric bypass.

Conditions

  • Analgesics, Opioid

Interventions

DRUG

Dexmedetomidine Injection [Precedex]

dexmedetomidine or remifentanil during laparoscopic gastric bypass

DRUG

Remifentanil

dexmedetomidine or remifentanil during laparoscopic gastric bypass

Sponsors & Collaborators

  • matthieu clanet

    lead OTHER

Principal Investigators

  • matthieu Clanet · Chirec

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-05
Primary Completion
2022-09-15
Completion
2022-10-15

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05004519 on ClinicalTrials.gov